258 related articles for article (PubMed ID: 19733604)
1. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
[TBL] [Abstract][Full Text] [Related]
2. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
3. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
4. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
5. The local lymph node assay and the assessment of relative potency: status of validation.
Basketter DA; Gerberick F; Kimber I
Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
[TBL] [Abstract][Full Text] [Related]
6. Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency.
Ryan CA; Chaney JG; Gerberick GF; Kern PS; Dearman RJ; Kimber I; Basketter DA
Cutan Ocul Toxicol; 2007; 26(2):135-45. PubMed ID: 17612980
[TBL] [Abstract][Full Text] [Related]
7. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
8. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.
Basketter DA; Gerberick GF; Kimber I
Cutan Ocul Toxicol; 2007; 26(4):293-301. PubMed ID: 18058304
[TBL] [Abstract][Full Text] [Related]
9. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
[TBL] [Abstract][Full Text] [Related]
11. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
[TBL] [Abstract][Full Text] [Related]
12. Classification of contact allergens according to potency: proposals.
Kimber I; Basketter DA; Butler M; Gamer A; Garrigue JL; Gerberick GF; Newsome C; Steiling W; Vohr HW
Food Chem Toxicol; 2003 Dec; 41(12):1799-809. PubMed ID: 14563405
[TBL] [Abstract][Full Text] [Related]
13. The local lymph node assay and skin sensitization testing.
Kimber I; Dearman RJ
Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
15. Potency and risk assessment of a skin-sensitizing disperse dye using the local lymph node assay.
Betts CJ; Dearman RJ; Kimber I; Maibach HI
Contact Dermatitis; 2005 May; 52(5):268-72. PubMed ID: 15899000
[TBL] [Abstract][Full Text] [Related]
16. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
17. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
[TBL] [Abstract][Full Text] [Related]
18. An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round.
Ehling G; Hecht M; Heusener A; Huesler J; Gamer AO; van Loveren H; Maurer T; Riecke K; Ullmann L; Ulrich P; Vandebriel R; Vohr HW
Toxicology; 2005 Aug; 212(1):69-79. PubMed ID: 15878228
[TBL] [Abstract][Full Text] [Related]
19. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
20. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]